Science Translational Medicine – “Combination Immunotherapy” for Melanoma and RCC

June 7, 2012

“This strategy was developed in Portland and a randomized phase II trial of this strategy is underway.”
From Bernard Fox, Ph.D., Chief, Molecular and Tumor Immunology at Earle A. Chiles Research Institute

Read the entire article from Science Transitional Medicine here: http://stm.sciencemag.org/content/4/137/137ra74?goback=%2Egde_1002197_member_122186197

 

 

2016-03-18T11:01:02+00:00